TOG Review (RCOG Journal)
MRCOG Part 2
Sexual and Reproductive Health
Differences of sexual development and their clinical implications
Key Statistics
- 1:4500–5000 — Live births with atypical genitalia
- 60–70% — Atypical genitalia due to CAH
- 90% — CAH cases from 21-OH deficiency
Don't-miss facts
-
DSD = differences of sex development; terms hermaphrodite/pseudohermaphrodite/intersex/sex reversal abolished
-
Atypical genitalia: 1 in 4500–5000 births; CAH causes 60–70% of cases; 21-OH deficiency = >90% of CAH (75% salt- wasting)
-
CAIS: XY, testes, AMH regresses müllerian ducts, no DHT → female genitalia, normal breasts, 1° amenorrhoea; usually raised female
-
Germ cell tumour risk: CAIS 0.8% < PAIS 15% < 17β-HSD3 deficiency 28% < gonadal dysgenesis 30–50% – drives gonadectomy timing
-
Initially assigned gender is the best predictor of adult gender identity
-
Neonate: exclude salt-wasting crisis first (electrolytes, 17OHP, glucose, urinary steroid profile), then karyotype, then testicular function (AMH, hCG stim)
-
Genitoplasty: 39% clitoral regrowth after childhood surgery; consent-driven surgery ban in some countries (e.g. Germany); vaginal dilatation success up to 80%
-
Chicago Consensus/Endocrine Society: feminising genitoplasty considered only for CAH with moderate–severe virilisation
46,XY DSD QUICK DIFFERENTIATOR
CAIS/PAIS: testes, AMH+, müllerian absent 5AR/17β-HSD3 deficiency: virilise at puberty
Abbreviation Key
- DSD — differences (disorders) of sex development
- 21-OH / 11β-OH — 21-hydroxylase / 11β-hydroxylase
- SRY — sex-determining region Y gene
- 3β-HSD — 3β-hydroxysteroid dehydrogenase
- AMH — anti-müllerian hormone
- DHEA — dehydroepiandrosterone
- DHT — dihydrotestosterone
- LH — luteinising hormone
- 5AR — 5α-reductase
- FSH — follicle-stimulating hormone
- CAIS/PAIS — complete/partial androgen insensitivity syndrome
- SHBG — sex hormone binding globulin
- 17β-HSD3 — 17β-hydroxysteroid dehydrogenase 3
- MRI — magnetic resonance imaging
- CAH — congenital adrenal hyperplasia
- MDT — multidisciplinary team
Source: Davies R, Davies L, Alleemudder D, MacDougall J. Differences of sexual development and their clinical implications. The Obstetrician & Gynaecologist 2020;22:257–266. doi:10.1111/tog.12667
MRCOG AI is an independent educational tool. It is not affiliated with, endorsed by, or connected to the Royal College of Obstetricians and Gynaecologists (RCOG).